JS03.7.A COMBINATION OF CDK4/6 AND MEK INHIBITION INCREASES ANTITUMOR EFFECTS IN PEDIATRIC HIGH-GRADE GLIOMA HARBORING BRAF MUTATION AND CDKN2A/B LOSS